IPO Boutique Brief: Looking Toward the Second Half
The IPO market ended the first half of the year on a sour note. Alumis Inc (ALMS) opened for trading $2.50 below the $16.00 issue price and has barely had a pulse in two sessions of trading. Unfortunately, its not even the worst biotech of the year. That honor goes to Metagenomi Inc’s (MGX) debut at[…]
